相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。The 2019 World Health Organization classification of tumours of the breast
Puay Hoon Tan et al.
HISTOPATHOLOGY (2020)
Ribociclib plus letrozole versus chemotherapy for postmenopausal women with hormone receptor-positive, HER2-negative, luminal B breast cancer (CORALLEEN): an open-label, multicentre, randomised, phase 2 trial
Aleix Prat et al.
LANCET ONCOLOGY (2020)
CDK4/6 inhibitor treatment for patients with hormone receptor-positive, HER2-negative, advanced or metastatic breast cancer: a US Food and Drug Administration pooled analysis
Jennifer J. Gao et al.
LANCET ONCOLOGY (2020)
E-cadherin to P-cadherin switching in lobular breast cancer with tubular elements
Matthias Christgen et al.
MODERN PATHOLOGY (2020)
How to treat lobular cancer in the adjuvant setting?
Dario Trapani et al.
CURRENT OPINION IN ONCOLOGY (2020)
CDK4/6 Inhibition in Early-Stage Breast Cancer: The New Standard?
Antonio C. Wolff
JOURNAL OF CLINICAL ONCOLOGY (2020)
Abemaciclib Combined With Endocrine Therapy for the Adjuvant Treatment of HR+, HER2-, Node-Positive, High-Risk, Early Breast Cancer (monarchE)
Stephen R. D. Johnston et al.
JOURNAL OF CLINICAL ONCOLOGY (2020)
Adjuvant chemotherapy in lobular carcinoma of the breast: a clinicopathological score identifies high-risk patient with survival benefit
Alexandre de Nonneville et al.
BREAST CANCER RESEARCH AND TREATMENT (2019)
Early breast cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up
F. Cardoso et al.
ANNALS OF ONCOLOGY (2019)
Clinical and Genomic Risk to Guide the Use of Adjuvant Therapy for Breast Cancer
Joseph A. Sparano et al.
NEW ENGLAND JOURNAL OF MEDICINE (2019)
Estimating the benefits of therapy for early-stage breast cancer: the St. Gallen International Consensus Guidelines for the primary therapy of early breast cancer 2019
H. J. Burstein et al.
ANNALS OF ONCOLOGY (2019)
Breast Cancer Index and prediction of benefit from extended endocrine therapy in breast cancer patients treated in the Adjuvant Tamoxifen-To Offer More? (aTTom) trial
J. M. S. Bartlett et al.
ANNALS OF ONCOLOGY (2019)
21-gene recurrence score and adjuvant chemotherapy decisions in patients with invasive lobular breast cancer
Xiang-Hong Chen et al.
BIOMARKERS IN MEDICINE (2019)
Mixed Invasive Ductal and Lobular Carcinoma of the Breast: Prognosis and the Importance of Histologic Grade
Otto Metzger-Filho et al.
ONCOLOGIST (2019)
Peritoneal Metastases from Breast Cancer: A Scoping Review
Michele Beniey
CUREUS JOURNAL OF MEDICAL SCIENCE (2019)
Relationship of histologic grade and histologic subtype with oncotype Dx recurrence scoreI3/4 retrospective review of 863 breast cancer oncotype Dx results
Kamaljeet Singh et al.
BREAST CANCER RESEARCH AND TREATMENT (2018)
Specific sites of metastases in invasive lobular carcinoma: a retrospective cohort study of metastatic breast cancer
Masayuki Inoue et al.
BREAST CANCER (2017)
Likelihood of late relapse assessed by the Breast Cancer Index (BCI) in LN-invasive lobular compared to invasive ductal carcinoma.
Raquel Nunes et al.
JOURNAL OF CLINICAL ONCOLOGY (2017)
An Analysis of Oncotype DX Recurrence Scores and Clinicopathologic Characteristics in Invasive Lobular Breast Cancer
Jesse L. Felts et al.
BREAST JOURNAL (2017)
Impact of the 21-gene recurrence score on outcome in patients with invasive lobular carcinoma of the breast
Scott Kizy et al.
BREAST CANCER RESEARCH AND TREATMENT (2017)
Relative Effectiveness of Adjuvant Chemotherapy for Invasive Lobular Compared With Invasive Ductal Carcinoma of the Breast
Schelomo Marmor et al.
CANCER (2017)
70-Gene Signature as an Aid to Treatment Decisions in Early-Stage Breast Cancer
F. Cardoso et al.
NEW ENGLAND JOURNAL OF MEDICINE (2016)
Comprehensive Molecular Portraits of Invasive Lobular Breast Cancer
Giovanni Ciriello et al.
CELL (2015)
Treatment choices for patients with invasive lobular breast cancer: a doctor survey
Carmel Jacobs et al.
JOURNAL OF EVALUATION IN CLINICAL PRACTICE (2015)
Pathological complete response and long-term clinical benefit in breast cancer: the CTNeoBC pooled analysis
Patricia Cortazar et al.
LANCET (2014)
Clinical benefit from neoadjuvant chemotherapy in oestrogen receptor-positive invasive ductal and lobular carcinomas
Y. Delpech et al.
BRITISH JOURNAL OF CANCER (2013)
Breast Cancer Index Identifies Early-Stage Estrogen Receptor-Positive Breast Cancer Patients at Risk for Early- and Late-Distant Recurrence
Yi Zhang et al.
CLINICAL CANCER RESEARCH (2013)
Effect of adjuvant chemotherapy in postmenopausal patients with invasive ductal versus lobular breast cancer
W. Truin et al.
ANNALS OF ONCOLOGY (2012)
Invasive lobular breast cancer: subtypes and outcome
Monica Iorfida et al.
BREAST CANCER RESEARCH AND TREATMENT (2012)
The genomic and transcriptomic architecture of 2,000 breast tumours reveals novel subgroups
Christina Curtis et al.
NATURE (2012)
Survival of breast cancer patients with meningeal carcinomatosis
H. Gauthier et al.
ANNALS OF ONCOLOGY (2010)
The molecular underpinning of lobular histological growth pattern: a genome-wide transcriptomic analysis of invasive lobular carcinomas and grade- and molecular subtype-matched invasive ductal carcinomas of no special type
Britta Weigelt et al.
JOURNAL OF PATHOLOGY (2010)
Preferred Reporting Items for Systematic Reviews and Meta-Analyses: The PRISMA Statement
David Moher et al.
PLOS MEDICINE (2009)
Aberrant Expression of E-cadherin in Lobular Carcinomas of the Breast
Leonard Da Silva et al.
AMERICAN JOURNAL OF SURGICAL PATHOLOGY (2008)
Invasive lobular carcinoma of the breast: Response to hormonal therapy and outcomes
Emad A. Rakha et al.
EUROPEAN JOURNAL OF CANCER (2008)
Distinct clinical and prognostic features of infiltrating lobular carcinoma of the breast: Combined results of 15 International Breast Cancer Study Group clinical trials
Bernhard C. Pestalozzi et al.
JOURNAL OF CLINICAL ONCOLOGY (2008)
Outcome prediction for estrogen receptor-positive breast cancer based on postneoadjuvant endocrine therapy tumor characteristics
Matthew J. Ellis et al.
JOURNAL OF THE NATIONAL CANCER INSTITUTE (2008)
Invasive lobular carcinoma classic type: Response to primary chemotherapy and survival outcomes
M Cristofanilli et al.
JOURNAL OF CLINICAL ONCOLOGY (2005)
Advanced methods in meta-analysis: multivariate approach and meta-regression
HC van Houwelingen et al.
STATISTICS IN MEDICINE (2002)
A comparison of methods to detect publication bias in meta-analysis
P Macaskill et al.
STATISTICS IN MEDICINE (2001)
分享论文
